Cell line · CVCL_0548
SaOS-2
Cancer cell line, Homo sapiens. Osteosarcoma. 100 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Download JSON
Cite this record
ConductScience Library. SaOS-2. Cell lines, record CVCL_0548. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_0548
On this page
Cell line
As Cellosaurus gives it.
- Name
- SaOS-2
- Accession
- CVCL_0548
- RRID
- RRID:CVCL_0548
- Synonyms
- SAOS-2, Saos-2, SAOS 2, Saos 2, Saos2, SaOs2, SAOS2, Sarcoma OSteogenic-2, SaOS, SAOS
- Species
- Homo sapiens (Human)
- Sex
- Female
- Age at sampling
- 11Y
- Category
- Cancer cell line
- Diseases
- Osteosarcoma (NCIt C9145); Osteosarcoma (ORDO Orphanet_668)
- Derived from
- Bone (in situ)
- Entry created
- 2012-04-04
- Entry updated
- 2026-06-25
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers100
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Mutant p53R273H disrupts PDPK1 homodimerization and contributes to PDPK1 activation. | Mol Oncol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| An inertial-based spiral device for separating rare tumor cells from liquid biopsies. | Bioeng Transl Med | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Vitamin D decreases tumor cell growth and invasiveness in primary malignant bone tumors in vitro. | J Bone Oncol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Preclinical Characterization of CLSP-1025, a First-in-Class, Mutation-Specific T-Cell Engager Targeting a Neoantigen Derived from a Common p53 Mutation. | Clin Cancer Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Oxidative base damage to telomeres sensitizes cancer cells to ATR inhibition. | Commun Biol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Genes Associated With Fracture Risk in Thoroughbred Horses Have Novel Roles in Osteogenesis. | Anim Genet | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Prognostic characteristics of disulfidptosis-related genes across cancers and their potential implications in osteosarcoma. | Sci Prog | 2026 | Its Methods give the RRID and name the line | PubMed | |
| DHX9 transcriptional upregulation and lactylation at K1024 fuels a glycolysis-histone lactylation loop in osteosarcoma. | J Transl Med | 2026 | Its Methods give the RRID and name the line | PubMed | |
| In Vitro Biological Evaluation of Titanium Implants Anodized With Aqueous Extract of Psidium guajava and Conventional Electrolytes. | Int J Biomater | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Ldha Regulates Osteosarcoma Lung Metastasis through Hedgehog Signaling. | Cancer Res Commun | 2026 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 100
See all 100 papersRelatives10
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Derived from it | HyCyte SaOS-2 KO-hRBFOX1 | CVCL_F4DM | Cell lines | |
| Derived from it | SAOS-alpha2beta1 | CVCL_X642 | Cell lines | |
| Derived from it | STA5 | CVCL_XF78 | Cell lines | |
| Derived from it | SaOS-LM1 | CVCL_9563 | Cell lines | |
| Derived from it | Saos-2 Tet-Off | CVCL_KU47 | Cell lines | |
| Derived from it | Saos-2-EGFP | CVCL_C8WB | Cell lines | |
| Derived from it | Saos-2-Luc | CVCL_C8WC | Cell lines | |
| Derived from it | Saos2-I | CVCL_9U47 | Cell lines | |
| Derived from it | SuperSOST C9 | CVCL_SA52 | Cell lines | |
| Derived from it | SuperSOST G5 | CVCL_SA53 | Cell lines |
Cell banks19
| Cell bank | Catalog number | Status | Source |
|---|---|---|---|
| ATCC | CRL-7939 | Discontinued | Cellosaurus |
| ATCC | HTB-85 | ATCC | |
| BCRJ | 0217 | BCRJ | |
| CCTCC | GDC0075 | Cellosaurus | |
| CLS | 300331 | CLS | |
| CancerTools | 161931 | CancerTools | |
| DSMZ | ACC-243 | DSMZ | |
| ECACC | 89050205 | ECACC | |
| Hysigen | TCH-C315 | Hysigen | |
| ICLC | HTL01001 | ICLC |
1 to 10 of 19
See all 19 cell banksData dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_0548
GET https://conductscience.org/api/cell-lines/v1/CVCL_0548/papers?page=2